Privacy preference

MEDtalks would like to keep you informed about the content that is most relevant to you. Click here for more information.


ASCO GU 2018: PROs and HRQoL of LATITUDE

Dr. Kim Chi, medical oncologist at the BC Cancer Agency in Vancouver, summarizes the results of the LATITUDE trial and the recently published patient-reported outcomes and health-related quality of life.

  • Sponsors

    This program is editorially independent and is financially supported by:

Related items